Efficacy of the Combination of Exenatide and Dapagliflozin in the Management of Diabetes and Weight Control: A Network Meta-Analysis
Wirksamkeit der Kombination aus Exenatid und Dapagliflozin zur Behandlung von Diabetes und Gewichtskontrolle: Netzwerk-Metaanalyse
Hormone and Metabolic Research · 04.11.2025
DOI: 10.1055/a-2737-6110 ↗Auf einen Blick
Vier RCTs mit 837 Patient:innen: Die Kombination senkte HbA1c und Gewicht stärker als Exenatid oder Dapagliflozin allein.
Fragestellung
Ist die Kombination aus Exenatid und Dapagliflozin wirksamer als jede Substanz allein zur Kontrolle von Diabetes und Gewicht?
Methode
Netzwerk-Metaanalyse von 4 RCTs aus 4 Datenbanken; Effektmaße als Mean Difference mit 95 %-KI; Qualitätsbewertung mit dem Cochrane Tool.
Ergebnisse
837 Patient:innen aus 4 Studien. HbA1c: MD -3,94 (95 %-KI -6,38 bis -1,49) vs. Exenatid und -6,54 (95 %-KI -8,90 bis -4,17) vs. Dapagliflozin. Gewicht: MD -1,07 (95 %-KI -1,76 bis -0,39) bzw. -1,82 (95 %-KI -2,52 bis -1,13).
Schlussfolgerung der Autor:innen
Die Kombination aus Dapagliflozin und Exenatid senkte Körpergewicht, HbA1c und Blutdruck wirksamer als jedes der beiden Medikamente allein.
Kernaussagen
- HbA1c stärker gesenkt als mit Exenatid oder Dapagliflozin allein
- Gewicht stärker gesenkt als mit beiden Monotherapien
- Vier RCTs mit 837 Patient:innen
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Netzwerk-Metaanalyse in der Zeitschrift Hormone and Metabolic Research, erschienen am 04.11.2025. Verfasst von Ahmed Abuali und 11 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Alexandria University Faculty of Medicine, Alexandria, Egypt.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Exenatide and dapagliflozin are medications commonly used in the controlling of T2DM. We aim to assess the efficacy of the combination of both drugs in the management of diabetes and weight control compared to the efficacy of each drug alone. We investigated four databases for relevant randomized clinical trials RCTs. Then a Network meta-analysis was made on the pertinent studies. Mean differences with 95% confidence intervals (CI) were utilized to pool continuous data, and the Cochrane Tool was employed to assess the quality of the included RCTs. The network meta-analysis was conducted using the R statistical software. We analyzed 837 patients from four studies. The combination had a significant decrease in HbA1c (mmol/L) compared to exenatide and dapagliflozin; [MD: -3.94, 95% (CI, -6.38 to -1.49)], [MD: -6.54, 95% (CI, -8.90 to -4.17)] respectively. Also, the combination showed a significant decrease in weight compared to dapagliflozin and exenatide alone; [MD: -1.07, 95% CI, (-1.76 to -0.39)] and [MD: -1.82, 95% CI, (-2.52 to -1.13)] respectively. The combination of dapagliflozin and exenatide lowers body weight, glycated hemoglobin, and blood pressure more effectively than any of the drugs alone. We suggest that this combination, according to its efficacy in improving the primary outcomes of diabetes, will result in general improvement of symptoms and decrease in complications.
Autor:innen und Institutionen
- Faculty of Medicine, Alexandria University Faculty of Medicine, Alexandria, Egypt.
- Internal Medicine, University of Maryland Baltimore School of Medicine, Baltimore, United States.
- Internal Medicine, Georgia Regents University Cancer Center, Augusta, United States.
- Faculty of Pharmacy, Damascus University, Damascus, Syrian Arab Republic.
- Faculty of Medicine, Minia University Faculty of Medicine, Minia, Egypt.
- Cardiology, Virginia Commonwealth University, GLEN ALLEN, United States.
Zitieren
APA
Abuali, A., Abdelhamid, A., Elsekaily, A. E., Seoudy, M., Elnaghy, M., Ragab, Y., Elkholy, M., Sharara, M., Mahrous, M., Alnasser, Y., Ragab, K. M., & Abdelhadi, N. (2025). Efficacy of the Combination of Exenatide and Dapagliflozin in the Management of Diabetes and Weight Control: A Network Meta-Analysis. Hormone and Metabolic Research. https://doi.org/10.1055/a-2737-6110
Vancouver
Abuali A, Abdelhamid A, Elsekaily AE, Seoudy M, Elnaghy M, Ragab Y, et al. Efficacy of the Combination of Exenatide and Dapagliflozin in the Management of Diabetes and Weight Control: A Network Meta-Analysis. Hormone and Metabolic Research. 2025. doi:10.1055/a-2737-6110
BibTeX
@article{Abuali2025,
author = {Abuali, Ahmed and Abdelhamid, Abdelrahman and Elsekaily, Ahmed Elsayed and Seoudy, Mohamed and Elnaghy, Mohamed and Ragab, Youssef and Elkholy, Mohammed and Sharara, Muhannad and Mahrous, Mostafa and Alnasser, Yusra and Ragab, Khaled Mohamed and Abdelhadi, Naser},
title = {Efficacy of the Combination of Exenatide and Dapagliflozin in the Management of Diabetes and Weight Control: A Network Meta-Analysis},
journal = {Hormone and Metabolic Research},
year = {2025},
doi = {10.1055/a-2737-6110}
}
EUVIMED